These AML patients responded poorly following treatment with old standard therapies.

Of the 24 sufferers with the mutation, 22 had a full remission. Of those, 13 relapsed within 1.4 years, but nine remained in remission when the study ended, with disease-free periods which range from two to almost eight years. ‘We believe that the use of intense consolidation therapy may possess contributed to the reduced amount of early relapses in these individuals,’ Bloomfield says. ‘We still should do larger studies to verify these findings, to better understand this disease and to develop curative targeted therapies.’.. Aggressive therapy best for certain acute myeloid leukemia patients A new study shows that acute leukemia individuals whose cancer cells show a genetic change that always predicts a swift return of the condition following remission may stay disease-free longer when given aggressive therapy.Related StoriesDisclosing genetic risk for CHD outcomes in lower low-density lipoprotein cholesterolDiet lacking soluble fiber promotes swelling in the intestines, leading to weight gainNew protein dietary supplement lowers cholesterol, prevents osteoporosisSIMCOR can be a prescription medicine utilized along with diet in people who cannot control their cholesterol levels by exercise and diet alone. SIMCOR is authorized to lower levels of elevated total cholesterol, LDL bad cholesterol and triglycerides, also to raise HDL good cholesterol. SIMCOR is used when treatment with simvastatin alone or niacin extended-release alone is not considered adequate. No additional advantage of SIMCOR on heart disease in addition to that demonstrated for niacin alone and simvastatin alone has been demonstrated.